San Miguel

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Atrial fibrillation

Closed trials

• Recruiting

  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  NCT05712200· Phase 3· Anthos Therapeutics, Inc.· Source

  Contact: Anthos Therapeutics a Novartis Company